1149 |
Advantage of 2nd Generation OCT; OCT Is Useful to Assess Complex Coronary Lesions |
Gary S. Mintz |
May. 13. 11 |
1148 |
Impact of Complete Revascularization Strategy |
Young-Hak Kim |
May. 13. 11 |
1147 |
What We Will Learn from FREEDOM and ISCHEMIA Trials ? |
Mun Kyung Hong |
May. 13. 11 |
1146 |
Does High SYNTAX Score Always Means Bypass Surgery in Multivessel Disease Patients ? |
Imad Sheiban |
May. 13. 11 |
1145 |
Asymptomatic Carotid Stenosis: Optimal Medical Treatment vs. Revascularization |
Jae-Hwan Lee |
May. 13. 11 |
1144 |
Is Protection Device of Benefit or Not ? |
Hsien-Li Kao |
May. 13. 11 |
1143 |
Normal Risk Symptomatic Patients, On-going Debate; CAS vs CEA? |
John R. Laird |
May. 13. 11 |
1142 |
IVUS-FFR: Optimal Cut-off of MLA |
Soo-Jin Kang |
May. 13. 11 |
1141 |
Appropriateness in Imaging: Why We Need to Pay Attention |
John McB. Hodgson |
May. 13. 11 |
1140 |
How and Why to Assess the Coronary Microvasculature |
William F. Fearon |
May. 13. 11 |